欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/0481/002
药品名称Fosrenol
活性成分
    • lanthanum(III)carbonate 500.0 mg
剂型Chewable tablet
上市许可持有人Takeda Pharmaceuticals International AG Ireland Branch
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • Ireland (IE)
    • Austria (AT)
      Fosrenol 500 mg Kautabletten
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Greece (GR)
    • Norway (NO)
    • Finland (FI)
    • Latvia (LV)
      Fosrenol 500 mg košļājamās tabletes
    • Estonia (EE)
      FOSRENOL
    • Cyprus (CY)
    • Slovakia (SK)
      Fosrenol 500 mg žuvacie tablety
    • Slovenia (SI)
    • Malta (MT)
    • Lithuania (LT)
      FOSRENOL 500 mg kramtomosios tabletės
许可日期2005/03/01
最近更新日期2025/09/26
药物ATC编码
    • V03AE03 lanthanum carbonate
申请类型
  • TypeLevel1：New Active Substance
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Full Dossier [Article 8.3(i)]
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase